Cargando…
Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139934/ https://www.ncbi.nlm.nih.gov/pubmed/36477202 http://dx.doi.org/10.1182/bloodadvances.2022007937 |
| _version_ | 1785033053664444416 |
|---|---|
| author | Katamesh, Bahga Nanaa, Ahmad He, Rong Viswanatha, David Nguyen, Phuong Greipp, Patricia Bessonen, Kurt Gangat, Naseema Begna, Kebede Mangaonkar, Abhishek Patnaik, Mrinal Hogan, William J. Tefferi, Ayalew Litzow, Mark Shah, Mithun Vinod Yi, Cecilia Arana Foran, James Badar, Talha Alkhateeb, Hassan B. Al-Kali, Aref |
| author_facet | Katamesh, Bahga Nanaa, Ahmad He, Rong Viswanatha, David Nguyen, Phuong Greipp, Patricia Bessonen, Kurt Gangat, Naseema Begna, Kebede Mangaonkar, Abhishek Patnaik, Mrinal Hogan, William J. Tefferi, Ayalew Litzow, Mark Shah, Mithun Vinod Yi, Cecilia Arana Foran, James Badar, Talha Alkhateeb, Hassan B. Al-Kali, Aref |
| author_sort | Katamesh, Bahga |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10139934 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101399342023-04-29 Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience Katamesh, Bahga Nanaa, Ahmad He, Rong Viswanatha, David Nguyen, Phuong Greipp, Patricia Bessonen, Kurt Gangat, Naseema Begna, Kebede Mangaonkar, Abhishek Patnaik, Mrinal Hogan, William J. Tefferi, Ayalew Litzow, Mark Shah, Mithun Vinod Yi, Cecilia Arana Foran, James Badar, Talha Alkhateeb, Hassan B. Al-Kali, Aref Blood Adv Research Letter The American Society of Hematology 2022-12-09 /pmc/articles/PMC10139934/ /pubmed/36477202 http://dx.doi.org/10.1182/bloodadvances.2022007937 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Katamesh, Bahga Nanaa, Ahmad He, Rong Viswanatha, David Nguyen, Phuong Greipp, Patricia Bessonen, Kurt Gangat, Naseema Begna, Kebede Mangaonkar, Abhishek Patnaik, Mrinal Hogan, William J. Tefferi, Ayalew Litzow, Mark Shah, Mithun Vinod Yi, Cecilia Arana Foran, James Badar, Talha Alkhateeb, Hassan B. Al-Kali, Aref Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title | Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title_full | Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title_fullStr | Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title_full_unstemmed | Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title_short | Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience |
| title_sort | clinical and prognostic impact of stag2 mutations in myeloid neoplasms: the mayo clinic experience |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139934/ https://www.ncbi.nlm.nih.gov/pubmed/36477202 http://dx.doi.org/10.1182/bloodadvances.2022007937 |
| work_keys_str_mv | AT katameshbahga clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT nanaaahmad clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT herong clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT viswanathadavid clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT nguyenphuong clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT greipppatricia clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT bessonenkurt clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT gangatnaseema clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT begnakebede clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT mangaonkarabhishek clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT patnaikmrinal clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT hoganwilliamj clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT tefferiayalew clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT litzowmark clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT shahmithunvinod clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT yiceciliaarana clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT foranjames clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT badartalha clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT alkhateebhassanb clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience AT alkaliaref clinicalandprognosticimpactofstag2mutationsinmyeloidneoplasmsthemayoclinicexperience |